| HealthPartners | Onasemnogene abeparvovec-xioi (Zolgensma®) – | 2025-07-01 |
| HealthPartners | Oncology - ado-trastuzumab emtansine (Kadcyla®), | 2025-07-01 |
| HealthPartners | Oncology - ado-trastuzumab emtansine (Kadcyla®), | 2025-07-01 |
| HealthPartners | Oncology - daratumumab and daratumumab | 2025-07-01 |
| HealthPartners | Oncology - daratumumab and daratumumab | 2025-07-01 |
| HealthPartners | Oncology - isatuximab-irfc (Sarclisa®) – Minnesota | 2025-07-01 |
| HealthPartners | Oncology - long-acting G-CSF | 2025-07-01 |
| HealthPartners | Oncology - long-acting G-CSF – Minnesota Health | 2025-07-01 |
| HealthPartners | Oncology - pembrolizumab (Keytruda®), | 2025-07-01 |
| HealthPartners | Oncology - sacituzumab govitecan-hziy (Trodelvy™) – | 2025-07-01 |